B-cell prolymphocytic leukemia historical perspective: Difference between revisions
Carlos Lopez (talk | contribs) No edit summary |
No edit summary |
||
(6 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{B-cell prolymphocytic leukemia}} | {{B-cell prolymphocytic leukemia}} | ||
{{CMG}}; {{AE}}{{Qurrat}},{{CLG}} | |||
== Overview == | == Overview == | ||
B-cell prolymphocytic leukemia was first described in 1974 by Galton | [[B cell|B-cell]] [[prolymphocytic leukemia]] was first described in 1974 by Galton David Abraham Goitein. | ||
==B-cell prolymphocytic leukemia== | ==B-cell prolymphocytic leukemia== | ||
B-cell prolymphocytic leukemia initially, when first described by Galton | [[B cell|B-cell]] [[prolymphocytic leukemia]] initially, when first described by Galton David Abraham Goitein. in 1974 was considered a variant of [[Chronic lymphocytic leukemia|chronic lymphoid leukemia]].<ref name="pmid4137136">{{cite journal |vauthors=Galton DA, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ |title=Prolymphocytic leukaemia |journal=Br. J. Haematol. |volume=27 |issue=1 |pages=7–23 |date=May 1974 |pmid=4137136 |doi= |url=}}</ref> In 1995 Ciril Rozman and Emilio Montserrat described the etilogy, [[classification]] and [[Natural history of disease|natural history]] of [[B cell|B-cell]] [[prolymphocytic leukemia]] in detail.<ref name="pmid7675049">{{cite journal |vauthors=Rozman C, Montserrat E |title=Chronic lymphocytic leukemia |journal=N. Engl. J. Med. |volume=333 |issue=16 |pages=1052–7 |date=October 1995 |pmid=7675049 |doi=10.1056/NEJM199510193331606 |url=}}</ref> | ||
}}</ref> | |||
[[Category:Leukemia]] | [[Category:Leukemia]] | ||
Line 14: | Line 13: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Disease]] | |||
[[Category:Hematology]] | |||
[[Category:Types of cancer]] | |||
[[Category:Oncology]] | |||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] |
Latest revision as of 19:21, 8 April 2019
B-cell prolymphocytic leukemia |
Differentiating B-cell prolymphocytic leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
B-cell prolymphocytic leukemia historical perspective On the Web |
American Roentgen Ray Society Images of B-cell prolymphocytic leukemia historical perspective |
FDA on B-cell prolymphocytic leukemia historical perspective |
CDC on B-cell prolymphocytic leukemia historical perspective |
B-cell prolymphocytic leukemia historical perspective in the news |
Blogs on B-cell prolymphocytic leukemia historical perspective |
Directions to Hospitals Treating B-cell prolymphocytic leukemia |
Risk calculators and risk factors for B-cell prolymphocytic leukemia historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2],Carlos A Lopez, M.D. [3]
Overview
B-cell prolymphocytic leukemia was first described in 1974 by Galton David Abraham Goitein.
B-cell prolymphocytic leukemia
B-cell prolymphocytic leukemia initially, when first described by Galton David Abraham Goitein. in 1974 was considered a variant of chronic lymphoid leukemia.[1] In 1995 Ciril Rozman and Emilio Montserrat described the etilogy, classification and natural history of B-cell prolymphocytic leukemia in detail.[2]
References
- ↑ Galton DA, Goldman JM, Wiltshaw E, Catovsky D, Henry K, Goldenberg GJ (May 1974). "Prolymphocytic leukaemia". Br. J. Haematol. 27 (1): 7–23. PMID 4137136.
- ↑ Rozman C, Montserrat E (October 1995). "Chronic lymphocytic leukemia". N. Engl. J. Med. 333 (16): 1052–7. doi:10.1056/NEJM199510193331606. PMID 7675049.